Search Results For ''

  • Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight

    No doubt, after many weeks with coronavirus, dubbed “COVID-19”, lingering in the background of U.S and Australian corporate reporting season, investment markets, have reacted strongly over the past week. On public health concerns and uncertainty over the economic impact, we saw a sell-off in equities and yield on “safe-haven” 10-year Treasuries being pushed to record

    Read More
    Public
  • New ASX listing Founders First acquires award winning Kangaroo Island Distillery

    Following the company’s successful $15 million IPO capital raising, Australian craft beverage company Founders First (ASX: FFL) has announced the acquisition of Kangaroo Island Distillery (KIS) for $1.5 million. The company has been busy since listing back in December 2019, with similar sized acquisitions in Hunter Valley and Moonee Ponds, and a significant convertible note

    Read More
    Public
  • Being defensive is currently paying off…

    Given so many coronavirus experts have appeared since its outbreak, we haven’t felt the need to add to the noise. But we have been closely monitoring the situation through macro data, bottom up company research, discussions with company management teams, with our partners here and offshore. The recent offshore and current ASX reporting season has

    Read More
    Public
  • Zoono successfully tests against coronavirus COVID-19, shares skyrocket

    Biotech company Zoono Group (ASX: ZNO) has reported that its lab tests against COVID-19 have shown their hand sanitiser product to have more than 99.99% efficacy in deactivating the coronavirus pathogens.  Conducted under strict European testing standards, the tests conducted identified Zoono’s Z-71 Microbe Shield hand sanitiser to be effective against a variety of pathogens

    Read More
    Public
  • Little Green Pharma to supply medicinal cannabis to underserviced German market

    Australian medicinal cannabis and healthcare company Little Green Pharma (ASX: LGP) has this morning announced a key purchase agreement with Berlin-based DEMECAN for the sale and export of up to 1000kg of dried cannabis flower or 48,000 units of medicinal cannabis per annum. The agreement makes LGP one of the first few companies to export

    Read More
    Public
  • With trade stalling in China, Eagle Health turns to Africa with new continental distributor

    As fears over the coronavirus outbreak continue to spread, health and nutritional product manufacturer Eagle Health (ASX: EHH) is set to diversify their distribution channels by entering a collaborative agreement with Amka Products which has a continental footprint throughout Africa.  The agreement will see AMKA, a market leader for manufacturing and distribution of health products

    Read More
    Public